Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

EV/OCF
Enterprise Value to OCF

25.5
Current
26.3
Median
5.9
Industry
Lower than median
Higher than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
25.5
=
Enterprise Value
10B SEK
/
Operating Cash Flow
392.9m SEK
All Countries
Close
Market Cap EV/OCF
SE
Biogaia AB
STO:BIOG B
11.1B SEK 25.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 641.9
US
Abbvie Inc
NYSE:ABBV
318.1B USD 22.4
US
Amgen Inc
NASDAQ:AMGN
142.2B USD 26.2
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD -115.7
US
Epizyme Inc
F:EPE
94.1B EUR -469.9
AU
CSL Ltd
ASX:CSL
135.7B AUD 34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 16.9
US
Seagen Inc
F:SGT
39.3B EUR -73.5
NL
argenx SE
XBRU:ARGX
36.2B EUR -133.1
 
SE
Biogaia AB
STO:BIOG B
Average EV/OCF: 22.7
25.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 641.9
US
Abbvie Inc
NYSE:ABBV
22.4
US
Amgen Inc
NASDAQ:AMGN
26.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.9
AU
CSL Ltd
ASX:CSL
34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -133.1

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More